Ramosetron

Drugbox
IUPAC_name = (1-methylindol-3-yl)- [(5"R")-4,5,6,7-tetrahydro- 3"H"-benzimidazol-5-yl] methanone

---

CAS_number = 132907-72-3
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 108000
DrugBank =
chemical_formula =
C=17 | H=17 | N=3 | O=1
molecular_weight = 279.33 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Ramosetron (INN) is a serotonin 5-HT₃ receptor antagonist for the treatment of nausea and vomiting. [cite journal |author=Fujii Y, Saitoh Y, Tanaka H, Toyooka H |title=Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery |journal=Anesth. Analg. |volume=90 |issue=2 |pages=472–5 |year=2000 |month=February |pmid=10648342 |doi= |url=http://www.anesthesia-analgesia.org/cgi/pmidlookup?view=long&pmid=10648342]

It is only licensed for use in Japan and selected Southeast Asian countries. It is commonly sold under the tradename Nasea. [ [http://www.mims-online.com/Page.aspx?menuid=mng&name=Nasea+amp Abriged prescribing information - Nasea (MIMS Philippines)] . Retrieved on June 13, 2008.]

References